Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kwality PharmaceuticalsBOM:539997 +0.35%65 Days Inventory is 82.38 as of Mar. 2026, which is 27% above its 10-year median of 64.68. GuruFocus rates BOM:539997 with a GF Score™ of 65/100 and a GF Value™ of ₹1,175.84 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 923 Drug Manufacturers companies, Kwality Pharmaceuticals ranks better than 72.59% on this metric.
The historical rank and industry rank for Kwality Pharmaceuticals's Days Inventory or its related term are showing as below:
BOM:539997'
s Days Inventory Range Over the Past 10 Years
Min: 39.34 Med: 64.68 Max: 213.45
Current: 115.6
During the past 13 years, Kwality Pharmaceuticals's highest Days Inventory was 213.45. The lowest was 39.34. And the median was 64.68.
BOM:539997's Days Inventory is ranked better than 72.59% of 923
companies
in the Drug Manufacturers industry
Industry Median: 164.87
vs BOM:539997: 115.60
Kwality Pharmaceuticals's Days Inventory
declined
from Mar. 2025 (125.29) to Mar. 2026 (82.38).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Kwality Pharmaceuticals's Inventory Turnover for the
three
months ended in Mar. 2026 was 1.11.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Kwality Pharmaceuticals's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.50.
Kwality Pharmaceuticals (BOM:539997) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Kwality Pharmaceuticals's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Kwality Pharmaceuticals's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Kwality Pharmaceuticals Days Inventory Related Terms
Kwality Pharmaceuticals Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Kwality Pharmaceuticals's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kwality Pharmaceuticals Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Kwality Pharmaceuticals's Days Inventory distribution charts can be found below:
* The bar in red indicates where Kwality Pharmaceuticals's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kwality Pharmaceuticals (BOM:539997) has a Days Inventory of 82.38 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Kwality Pharmaceuticals and its competitors. This is 27% above median its historical median of 64.68. Over the past decade, Kwality Pharmaceuticals' Days Inventory has ranged from 39.34 to 213.45. According to the industry distribution chart, Kwality Pharmaceuticals ranks #253 out of 923 companies in the Drug Manufacturers industry, placing it in the top 27.4%.
Is Kwality Pharmaceuticals' Days Inventory too high?
Kwality Pharmaceuticals' current Days Inventory of 82.38 is 27% above median its 10-year median of 64.68. Over the past 10 years, this metric has ranged from a low of 39.34 to a high of 213.45. The Drug Manufacturers industry median Days Inventory is 164.87. Kwality Pharmaceuticals' value of 82.38 is 50% below this industry median. Based on the distribution chart, Kwality Pharmaceuticals ranks #253 out of 923 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Kwality Pharmaceuticals has a GF Score™ of 65/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Kwality Pharmaceuticals' Days Inventory compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Kwality Pharmaceuticals ranks #253 out of 923 companies for Days Inventory. This puts Kwality Pharmaceuticals in the upper half of its industry. The industry median Days Inventory is 164.87. Kwality Pharmaceuticals' value of 82.38 is 50% below this benchmark. Historically, Kwality Pharmaceuticals' own Days Inventory has ranged from 39.34 to 213.45 over the past decade. While the company's 10-year median is 64.68 vs. the industry median of 164.87, Kwality Pharmaceuticals has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.87, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kwality Pharmaceuticals's current Days Inventory of 82.38 is 50% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Kwality Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kwality Pharmaceuticals's current Days Inventory is 82.38, which is 27% above median its own 10-year median of 64.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kwality Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Kwality Pharmaceuticals (BOM:539997) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹1,175.84, compared to a current price of ₹2,551.10 — trading 117% above its estimated fair value. The current Days Inventory is 82.38, which is 27% above median its 10-year median of 64.68 and 50% below the Drug Manufacturers industry median of 164.87. Kwality Pharmaceuticals' overall GF Score™ is 65/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Kwality Pharmaceuticals (BOM:539997), the current Days Inventory is 82.38 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kwality Pharmaceuticals (BOM:539997) Overvalued in 2026?
Based on GuruFocus' analysis, Kwality Pharmaceuticals stock appears to be overvalued.
The current stock price of ₹2,551.10 is trading 117% above its estimated GF Value™ of ₹1,175.84.
GuruFocus considers Kwality Pharmaceuticals to be Significantly Overvalued.
Key valuation signals for BOM:539997:
Days Inventory: 82.38 (27% above median its 10-year median of 64.68)
GF Value™: ₹1,175.84 vs. price of ₹2,551.10 (117% above fair value)
Industry Position: 50% below the Drug Manufacturers median (#253 of 923)
No single metric tells the full story. See the BOM:539997 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kwality Pharmaceuticals Ltd is an India-based pharmaceutical company. It is principally engaged in manufacturing finished pharmaceutical formulations in a dosage form. The company manufactures and exports pharmaceutical formulations in liquid orals, dry syrups, tablets, capsules, sterile powder for injections, and small-volume injectables.
65GF Score
Get the complete analysis for BOM:539997
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:539997 has been successfully added to your 
